Elena B. Yarovaya

Moscow, MOW, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Fortelyzin in the treatment of acute ischemic stroke in patients ≥80 years old: data from the observational study FORPI registry

Fortelyzin in the treatment of acute ischemic stroke in patients ≥80 years old: data from the observational study FORPI registry

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: April 15, 2026

Fortelizin in bridging therapy of acute ischemic stroke: data from the observational study FORPI registry

Fortelizin in bridging therapy of acute ischemic stroke: data from the observational study FORPI registry

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: March 05, 2026

Fortelyzin for acute ischaemic stroke treatment in an extended (4.5 to 24 hours from the onset of symptoms) time window: data from the observational study FORPI registry

Fortelyzin for acute ischaemic stroke treatment in an extended (4.5 to 24 hours from the onset of symptoms) time window: data from the observational study FORPI registry

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: February 09, 2026

Fortelyzin for acute ischaemic stroke treatment: an open, prospective, non-interventional, observational study FORPI registry

Fortelyzin for acute ischaemic stroke treatment: an open, prospective, non-interventional, observational study FORPI registry

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: January 12, 2026

A "risk score scale" based on computed tomography angiography of the coronary arteries to assess the risk of cardiovascular events in the first year after acute coronary syndrome

A "risk score scale" based on computed tomography angiography of the coronary arteries to assess the risk of cardiovascular events in the first year after acute coronary syndrome

Journal: Terapevticheskii arkhiv

Published: December 16, 2025

Thrombolysis With the Non-Immunogenic Staphylokinase for Acute Ischemic Stroke in the FORPI Registry: An Observational Study.

Thrombolysis With the Non-Immunogenic Staphylokinase for Acute Ischemic Stroke in the FORPI Registry: An Observational Study.

Journal: Stroke

Published: November 26, 2025

Vitaphospholip® (water-soluble phosphatidylcholine) in the treatment of combined hyperlipidemia: a randomized, placebo-controlled clinical trial.

Vitaphospholip® (water-soluble phosphatidylcholine) in the treatment of combined hyperlipidemia: a randomized, placebo-controlled clinical trial.

Journal: Biomeditsinskaia khimiia

Published: November 10, 2025

Characteristics and 5-year outcomes in patients with chronic lymphocytic leukemia receiving ibrutinib (a real-world study)

Characteristics and 5-year outcomes in patients with chronic lymphocytic leukemia receiving ibrutinib (a real-world study)

Journal: Terapevticheskii arkhiv

Published: May 23, 2025

Registry Study "HOSTA CHF": Characterization of the State of the Chronic Heart Failure Treatment Delivery System in Russian Federation Regions: Revealing, Diagnostics, Treatment, Observation.

Registry Study "HOSTA CHF": Characterization of the State of the Chronic Heart Failure Treatment Delivery System in Russian Federation Regions: Revealing, Diagnostics, Treatment, Observation.

Journal: Kardiologiia

Published: March 07, 2025

Ultra-Low-Dose Inhalation of Melphalan as an Additional Treatment for COVID-19-Associated Pneumonia.

Ultra-Low-Dose Inhalation of Melphalan as an Additional Treatment for COVID-19-Associated Pneumonia.

Journal: Journal of clinical medicine

Published: February 17, 2025

Prognostic outcome of intravenous thrombolysis with non-immunogenic staphylokinase in patients aged ≥ 60 years with acute ischemic stroke by THRIVE scale.

Prognostic outcome of intravenous thrombolysis with non-immunogenic staphylokinase in patients aged ≥ 60 years with acute ischemic stroke by THRIVE scale.

Journal: Journal of thrombosis and thrombolysis

Published: December 26, 2024

Intraarterial intrathrombus thrombolysis with non-immunogenic staphylokinase vs surgery in patients with acute limb ischemia: protocol of a multicenter, open-label, randomized clinical trial FORAT

Intraarterial intrathrombus thrombolysis with non-immunogenic staphylokinase vs surgery in patients with acute limb ischemia: protocol of a multicenter, open-label, randomized clinical trial FORAT

Journal: Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery

Published: October 08, 2024

Showing 1-12 of 39

Last Updated: 09/26/2026